drugset / Trial / NCT04574791

Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty

NCT04574791

Unknown 240 enrolled Rothman Institute Orthopaedics
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, cluster-randomized, two-arm, comparative study aimed at determining whether addition of tizanidine ( an oral muscle relaxant) to a multimodal pain regimen following primary TKA reduces opioid consumption.

Timeline

Start
2020-09-03
Primary completion
2021-09-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tizanidine Small molecule 2 mg Oral

Indications

No indication recorded.